Table 1. Quantification of the... | American Society of Hematology

Table 1.

Quantification of the expression of CD20, CD55, and CD59 in cells from patients with B-lymphoproliferative disorders and healthy donors

	n	Molecules/cell (× 10³)
	n	CD20	CD55	CD59
B-CLL	33	31.9 ± 26^*	9.7 ± 4^*	12.1 ± 6
Nonsensitive	24	18.7 ± 12^*	9.4 ± 5^*	12.8 ± 7
Sensitive^1-160	9	67.0 ± 20	10.4 ± 4^*	10.3 ± 6
MCL	16	113.2 ± 39	11.9 ± 5	9.0 ± 6
FL	4	96.0 ± 38	10.3 ± 4	16.5 ± 10
HCL	2	162.2 ± 7	2.1 ± 1	9.8 ± 11
Healthy donors	19	94.9 ± 37	13.6 ± 29	12.2 ± 4

	n	Molecules/cell (× 10³)
	n	CD20	CD55	CD59
B-CLL	33	31.9 ± 26^*	9.7 ± 4^*	12.1 ± 6
Nonsensitive	24	18.7 ± 12^*	9.4 ± 5^*	12.8 ± 7
Sensitive^1-160	9	67.0 ± 20	10.4 ± 4^*	10.3 ± 6
MCL	16	113.2 ± 39	11.9 ± 5	9.0 ± 6
FL	4	96.0 ± 38	10.3 ± 4	16.5 ± 10
HCL	2	162.2 ± 7	2.1 ± 1	9.8 ± 11
Healthy donors	19	94.9 ± 37	13.6 ± 29	12.2 ± 4

P < .02 versus healthy donors.

P < .001 sensitive B-CLL versus nonsensitive B-CLL.